Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Susan O’Brien et al.|The Lancet Oncology|2014Cited by 1.3k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Jessica C. Hassel et al.|New England Journal of Medicine|2021Cited by 869